文献速递消化内镜消化道肿瘤与早癌

新型机器人臂辅助内镜黏膜下剥离术平台联合增强牵引治疗胃肿瘤:首次人体前瞻性初步研究

A novel robotic arm-assisted endoscopic submucosal dissection platform with augmented traction for gastric neoplasms: a first-in-human prospective pilot study (with videos).
PubMed 文献 · Gastrointest Endosc · 2025-09-15

该首次人体前瞻性初步研究纳入15例连续胃肿瘤患者,评估机器人臂辅助内镜黏膜下剥离术(R-ESD)的临床性能。所有患者均实现整块切除和R0切除(100%),平均总手术时间28.8分钟,中位机器人辅助剥离时间14.3分钟,剥离速度48.2 mm²/min。R-ESD可行且安全,可能通过增强牵引提高手术安全性和性能。

要点

  • R-ESD在胃肿瘤中实现100%整块切除和R0切除。
  • 平均总手术时间28.8分钟,剥离速度48.2 mm²/min。
  • 标本损伤发生4例(26.7%),需关注操作安全性。

核心结论

  • R-ESD在胃内镜黏膜下剥离术中可行且安全,整块切除率高、剥离速度快。
  • R-ESD有望通过增强牵引改善手术安全性和性能。

研究设计与样本

  • 首次人体前瞻性初步研究,2024年6月至9月在韩国大学医疗中心连续纳入15例接受R-ESD的胃肿瘤患者。
  • 主要结局为整块切除。

主要发现

  • 所有患者均实现整块切除和R0切除(100%)。
  • 73.3%的肿瘤位于胃下三分之一(34.7 ± 5.8 mm),诊断为腺癌(53.3%)或低级别腺瘤(47.7%)。
  • 平均总手术时间28.8分钟,中位机器人辅助剥离时间14.3分钟,剥离速度48.2 mm²/min。
  • 标本损伤发生4例(26.7%)。
  • 机器人臂中位抓取次数3.9次/例,RDT/TPT比值为53.8%;下部和中部/上部病变比较显示RDT、抓取次数和RDT/TPT比值呈增加趋势。

临床怎么用

  • R-ESD可作为胃肿瘤内镜黏膜下剥离术的一种可行新方法,具有高整块切除率和较快剥离速度。
  • 增强牵引可能有助于提高手术安全性和性能,但需注意标本损伤风险。

局限性

  • 首次人体前瞻性初步研究,样本量小(15例),需更大规模研究验证。
  • 研究在单一中心进行,结果外推需谨慎。
  • 未报告长期随访结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Robotic arm-assisted endoscopic submucosal dissection (R-ESD) facilitates visualization of the submucosal dissection plane and aids complete tumor resection. However, the practicality of a robotic arm for gastric neoplasms remains unclear. This study aimed to evaluate the clinical performance of minimally invasive gastric R-ESD. METHODS: A total of 15 consecutive patients who underwent R-ESD between June 2024 and September 2024 at the Korea University Medical Center were prospectively enrolled and analyzed. The primary outcome was en bloc resection. RESULTS: All patients underwent both en bloc and R0 resections (100%). The majority of tumors (73.3%) were located in the lower third of the stomach (34.7 ± 5.8 mm) and were diagnosed as adenocarcinoma (53.3%) or low-grade adenoma (47.7%). The mean total procedure time (TPT) was 28.8 minutes and the median robot-assisted dissection time (RDT) was 14.3 minutes, achieving a dissection speed of 48.2 mm2/min. Specimen injury occurred in 4 cases (26.7%). The robotic arm conducted a median of 3.9 grasps per procedure, with an RDT/TPT ratio of 53.8%. A comparison between lower and middle/upper lesions revealed an increased pattern of RDT, grasps, and RDT/TPT ratio. The total NASA-TLX score was strongly correlated with the number of grasps, RDT/TPT ratio, and TPT. CONCLUSIONS: R-ESD proved feasible and safe in gastric endoscopic submucosal dissection through high en bloc resection rates and dissection speed. R-ESD holds promise for improving procedural safety and performance through augmented traction.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Jeon HJ, Keum B, Lee B, et al. A novel robotic arm-assisted endoscopic submucosal dissection platform with augmented traction for gastric neoplasms: a first-in-human prospective pilot study (with videos). Gastrointest Endosc. 2025. PMID: 40962233. doi:10.1016/j.gie.2025.09.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。